ARTICLE | Clinical News
MORAb-009 regulatory update
April 21, 2008 7:00 AM UTC
The EC granted Orphan Drug designation to Eisai's MORAb-009 to treat pancreatic cancer. The IgG1 antibody against glycoprotein-9 ( GP-9) is in Phase II testing in patients with inoperable pancreatic ...